Pharmaceutical - Recordati

Filter

Current filters:

Recordati

Popular Filters

Recordati posts sales growth and significant margin improvement in 1st-qtr 2014

07-05-2014

Italian drugmaker Recordati posted first-quarter 2014 financials, showing the consolidated revenues grew…

FinancialPharmaceuticalRecordati

Recordati gains certain rights to Apricus’ Vitaros

10-02-2014

Italian drugmaker Recordati has signed an exclusive license agreement with the USA’s Apricus Biosciences…

Apricus BioscienceEastern EuropeLicensingMen's HealthPharmaceuticalRecordatiRest of the WorldTurkeyVitaros

Recordati expects to report 8% sales growth for 2013

16-01-2014

Italian drugmaker Recordati revealed that its revenues for full-year 2013 are expected to be more than…

FinancialPharmaceuticalRecordati

DSMB backs continuation of Erytech’s Ph IIb study of Graspa

12-11-2013

French cancer focused drug developer Erytech Pharma says that an independent Data and Safety Monitoring…

Erytech PharmaGraspaHematologyOncologyPharmaceuticalRecordatiResearch

Italy's Recordati to acquire Spanish drugmaker

09-09-2013

In a second takeover deal this year, Italian drugmaker Recordati (RC: MI) says it has signed agreements…

CitrafleetGastro-intestinalsLab Casen FleetMergers & AcquisitionsPharmaceuticalRecordatiWomen's Health

Recordati posts 13.8% rise in 1st-half sales

25-07-2013

Italian drugmaker Recordati (RC: MI), which just yesterday announced it was acquiring a 90% stake in…

FinancialPharmaceuticalRecordati

Recordati acquires Tunisian drugmaker

25-07-2013

Italian drugmaker Recordati (RC: MI) has singed announces the signature of the agreements covering the…

GenericsMergers & AcquisitionsOpalia PharmaPharmaceuticalRecordati

Recordati posts 1st-qrt revenue rise of 11%, boosted by international sales

09-05-2013

Italian drugmaker Recordati (RC: MI) has reported an 11.4% rise to 244.6 million euros ($391.8 million)…

FinancialPharmaceuticalRecordati

Italy's Recordati posts solid 2012 result, as sales rise 8.7%

12-02-2013

Italian drugmaker Recordati (RC: MI) yesterday posted financial results for 2012, with consolidated revenue…

FinancialPharmaceuticalRecordati

Recordati buys US portfolio of drugs from Lundbeck

17-12-2012

Italian drugmaker Recordati *RC: MI) has signed an agreement for the acquisition of all rights concerning…

LundbeckMergers & AcquisitionsNorth AmericaPharmaceuticalRare diseasesRecordati

Recordati licenses Graspa from Erytech in Europe

25-11-2012

Italian drugmaker Recordati (RC: MI) says it has entered into an agreement with French development-stage…

Erytech PharmaEuropeGraspaLicensingOncologyPharmaceuticalRecordati

Recordati acquires a portfolio of OTC products in Russia

16-10-2012

Italian drugmaker Recordati (RC: MI) yesterday announced the signature of the agreements covering the…

AkvionEuropeMergers & AcquisitionsPharmaceuticalRecordati

Recordati acquires Poland's Farma-Projekt

03-08-2012

Italian drugmaker Recordati (RC: MI) said yesterday that it has signed an agreement to acquire 100% of…

Farma-ProjektGenericsMergers & AcquisitionsPharmaceuticalRecordati

Recordati sales up, despite Zanidip patent loss

12-02-2012

Italian drugmaker Recordati (REC: MI) on Friday reported full-year 2011 results, with consolidated revenue…

FinancialPharmaceuticalRecordatiZanidip

Recordati’s Normosang now approved in Russia; posts strong financials

08-11-2011

Italian drugmaker Recordati (REC: MI) and wholly-owned subsidiary Orphan Europe announced that Normosang,…

EuropeFinancialNormosangPharmaceuticalRare diseasesRecordatiRegulation

Back to top